Results 111 to 120 of about 283,019 (191)

Erythrocyte Antibodies in AIDS are associated with mycobacteriosis and hypergammaglobulinemia [PDF]

, 1990
A. Matuschke, AP Rapoport, B. Gathof, B. Heinrich, F. -D. Goebel, FJ Raal, J Lelie van der, J. R. Bogner, L Morris, LI Zon, LI Zon, M Adams, MH McGinniss, P Zauber, PT Toy, PT Toy, PY Lepennec, R Perricone, U. Bäcker, V Daniel, Y Inada, Y Schoenfeld   +21 more
core   +1 more source

Navigating the New Therapeutic Landscape: Innovative Strategies for Overcoming Resistance and Degeneration. [PDF]

Biomol Ther (Seoul)
Ko HJ, Lee CH.
europepmc   +1 more source

From Scarcity to Survival: Adaptive Strategies of A549 Lung Cancer Cells Under Serum Starvation. [PDF]

Thorac Res Pract
Mukhtarova G, Ozdenizer C, Ece D, Mert U, Caner A.   +4 more
europepmc   +1 more source

BRAF inhibitor resistance in melanoma: from resistance mechanisms to therapeutic innovations. [PDF]

Mol Biomed
Shang Y, Cao T, Li J, Li J, Zhang L, Ma Q, Feng L, Zhao H.   +7 more
europepmc   +1 more source

Evaluating temozolomide for pediatric adamantinomatous craniopharyngiomas using microspheroid-based drug screening. [PDF]

Childs Nerv Syst
Cavalheiro S, Pavon LF, de Farias CB, da Silva NS, Nascimento FB, Sibov TT, Rodrigues JB, Dastoli PA, Suzuki FS, Watanabe RA, Kim IHT, Lichtenfels M, da Silva CA, Cappellano A, da Costa MDS.   +14 more
europepmc   +1 more source

Oxaliplatin upregulates Cyr61 expression by inhibiting the Hippo-YAP pathway which contributes to drug resistance of colorectal cancer cells. [PDF]

Discov Oncol
Lu P, Zheng C, Zhang J, Zhu X, Chen X, Zhang J, Cao Y, Huang Z.   +7 more
europepmc   +1 more source

Forkhead box transcription factors in cancer initiation, progression and chemotherapeutic drug response

Frontiers in Oncology, 2014
Eric W-F Lam, Ana R Gomes
doaj   +1 more source

Natural Isothiocyanates Block Adhesion and Invasion of Gemcitabine- and Cisplatin-Resistant Bladder Cancer Cell Lines. [PDF]

Molecules
Rutz J, Grein T, Laqua M, Benhassine K, Perktas E, Cinatl J, Thomas A, Chun FK, Haferkamp A, Juengel E, Tsaur I, Markowitsch SD, Blaheta RA.   +12 more
europepmc   +1 more source

Therapeutic targeting of cancer stem cell-specific surface glycans and glycoproteins. [PDF]

Discov Oncol
Al-Khreisat MJ, Abdulsahib WK, Jasim IK, Malathi H, Nayak PP, Anand DA, Mukherjee G, Sinha A, Ruziyeva G.   +8 more
europepmc   +1 more source

Unraveling Immunotherapy Resistance in Solid Tumors: Decoding Mechanisms and Charting Future Therapeutic Landscapes. [PDF]

Oncol Res
Wang H, Xie J, Li N, Liu Q, Song W, Chen W, Peng C, Tang H.   +7 more
europepmc   +1 more source